SALES · INDEXED 100 → 283 · 8 PROJECTS · 20+ LAUNCHES 5-YR · 39% CAGR
- Scope
- top-5 pharma, CIS
- Baseline
- pre-program, 5-yr
- Role
- analytics & program lead
// CHALLENGE
The business was compounding at a 39% CAGR, and growth had to come from many directions at once — new launches, new territories, a larger field force — with no shared analytical backbone tying targeting, coverage and performance together. Run each expansion ad hoc and the gains don't compound; they cancel each other out.
// APPROACH
I led the analytical engine behind a five-year national expansion — 8 projects and 20+ product launches — and directed the cross-functional teams (data scientists, business partners and analysts) that ran it: KPI design, customer segmentation, coverage and territory redesign, and dashboard rollout, with Lean discipline to keep targeting tight as the field force grew.
- KPI design & dashboards — one performance backbone across 8 expansion projects
- Segmentation & coverage redesign — Lean targeting as the field force grew +52%
- Launch analytics — 20+ product launches sequenced on the same operating model